SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Trickle Portfolio
An SI Board Since October 2000
Posts SubjectMarks Bans
1784 65 0
Emcee:  tuck Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1334Probably it would. I've regarded Evotec as a competitor to Aurora, which watuck-1/20/2003
1333If they had a Nasdaq quote, would Evotec be in the portfolio ? HAMBURG, Germanynigel bates-1/20/2003
1332Hmmm. I might be able to sell them to guys at the gym who've maxed out on thtom pope-1/19/2003
1331>> What's a strengthening catalyst << I believe, but do not knoscaram(o)uche-1/19/2003
1330What's a strengthening catalyst? <i>RESEARCH ALERT-Friedman ups Watsotom pope-1/17/2003
1329Didn't realize BRKS played in the space. They can certainly hype with best tuck-1/14/2003
1328DES MOINES, Iowa and PALO ALTO, Calif., Jan. 13 /PRNewswire/ -- DuPont will gainnigel bates-1/13/2003
1327>>ABI Says No More Layoffs Anticipated By a GenomeWeb staff reporter SAtuck-1/9/2003
1326Trickle sold ABI at ~$22 on IP and earnings concerns. With ABI now under $17, Ituck-1/8/2003
1325>>BOTHELL, Wash. and VENLO, Netherlands, Jan. 8 /PRNewswire-FirstCall/ - Qtuck-1/8/2003
1324A teeny deal, but of interest to portfolio companies . . . >>HOLLISTONtuck-1/7/2003
1323Nah. Maybe I don't know what they've become in the past five years. I scaram(o)uche-1/7/2003
1322>>I said that productivity remained a focus, in face of the "no big ttuck-1/7/2003
1321>> that was my theory for the reagent and consumable companies << Iscaram(o)uche-1/7/2003
1320Reagents are tough. Academics spend a ton. You need to be fast to maintain marscaram(o)uche-1/7/2003
1319I've noticed tech's share price weakening considerably and it follows a keokalani'nui-1/7/2003
1318>>FSH fires into a good place for this restricted-budget time. They sell stuck-1/7/2003
1317FSH fires into a good place for this restricted-budget time. They sell stuff thscaram(o)uche-1/7/2003
1316Wonder if this is good news for trickle in general, or just FSH in particular ( tuck-1/7/2003
1315MDZ up in Toronto, down in the US. This news isn't enough to offset the rectuck-1/7/2003
1314IP issues. Apparently, HTS' systems use gratings instead of prisms: htsbiotuck-1/6/2003
1313>>BILLERICA, Mass.--(BUSINESS WIRE)--Jan. 6, 2003--Bruker Daltonics Inc. (tuck-1/6/2003
1312BCOR has their own program in this area, a good year behind. I have to wonder atuck-1/6/2003
1311Molecular Devices (MDCC-NNM) by R.W. Baird (16.02, Dec. 27) We are increasing oumopgcw-1/5/2003
1310JPM H&Q healthcare conference this week. Any of these companies worth a shiArt M-1/2/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News